Alphabet 13F annual report

Alphabet is an investment fund managing more than $1.97 trillion ran by Marsida Saraci. There are currently 42 companies in Mrs. Saraci’s portfolio. The largest investments include GitLab and Arm Holdings Plc, together worth $806 billion.

Limited to 30 biggest holdings

$1.97 trillion Assets Under Management (AUM)

As of 26th July 2024, Alphabet’s top holding is 9,758,333 shares of GitLab currently worth over $485 billion and making up 24.6% of the portfolio value. Relative to the number of outstanding shares of GitLab, Alphabet owns less than 0.8% of the company. In addition, the fund holds 1,960,784 shares of Arm Holdings Plc worth $321 billion. The third-largest holding is Revolution Medicines Inc worth $206 billion and the next is Crowdstrike Inc worth $164 billion, with 427,895 shares owned.

Currently, Alphabet's portfolio is worth at least $1.97 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Alphabet

The Alphabet office and employees reside in Mountain View, California. According to the last 13-F report filed with the SEC, Marsida Saraci serves as the Vice President, Deputy Controller at Alphabet.

Recent trades

In the most recent 13F filing, Alphabet revealed that it had opened a new position in Tempus Ai Inc and bought 1,551,102 shares worth $54.3 billion.

The investment fund also strengthened its position in Revolution Medicines Inc by buying 5,563 additional shares. This makes their stake in Revolution Medicines Inc total 5,307,075 shares worth $206 billion. Revolution Medicines Inc soared 39.2% in the past year.

On the other hand, there are companies that Alphabet is getting rid of from its portfolio. Alphabet closed its position in Invivyd Inc on 2nd August 2024. It sold the previously owned 4,527,122 shares for $20.1 billion. Marsida Saraci also disclosed a decreased stake in Crowdstrike Inc by 0.5%. This leaves the value of the investment at $164 billion and 427,895 shares.

One of the largest hedge funds

The two most similar investment funds to Alphabet are Seizert Capital Partners and Nicholas Hoffman ,. They manage $1.97 trillion and $1.97 trillion respectively.


Marsida Saraci investment strategy

Alphabet’s portfolio is diversified across 3 sectors. Currently, their heaviest sector is Technology — making up 41.3% of the total portfolio value. The fund focuses on investments in the United States as 50.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 10% of the total holdings value. On the other hand, small-cap stocks make up only 4.8% of the portfolio. The average market cap of the portfolio companies is close to $7.58 billion.

The complete list of Alphabet trades based on 13F SEC filings

These positions were updated on August 2nd based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
GitLab Inc.
No change
9,758,333
$485,184,317,000 24.58%
Arm Holdings Plc
No change
1,960,784
$320,823,478,000 16.25%
Revolution Medicines Inc
0.10%
5,307,075
$205,967,580,000 10.43%
Crowdstrike Holdings Inc
50.00%
427,895
$163,965,085,000 8.31%
Freshworks Inc
No change
12,336,643
$156,551,999,000 7.93%
Dexcom Inc
42.10%
1,036,937
$117,567,917,000 5.96%
UiPath, Inc.
No change
7,034,337
$89,195,393,000 4.52%
Prime Medicine Inc
No change
15,062,498
$77,421,240,000 3.92%
Snowflake Inc.
No change
535,604
$72,354,744,000 3.66%
Verve Therapeutics Inc
No change
12,349,086
$60,263,539,000 3.05%
Planet Labs Pbc
No change
31,942,641
$59,413,312,000 3.01%
Tempus Ai Inc
Opened
1,551,102
$54,288,570,000 2.75%
Invivyd Inc
Closed
4,527,122
$20,100,421,000
Sana Biotechnology Inc
No change
2,812,500
$15,356,250,000 0.78%
Relay Therapeutics, Inc.
No change
1,568,753
$10,228,270,000 0.52%
Desktop Metal, Inc.
Closed
11,048,730
$9,722,882,000
Vera Therapeutics Inc
No change
241,264
$8,728,932,000 0.44%
Lyell Immunopharma Inc
No change
5,865,125
$8,504,431,000 0.43%
Oscar Health, Inc.
No change
481,988
$7,625,050,000 0.39%
Beam Therapeutics Inc.
No change
321,604
$7,535,182,000 0.38%
Tscan Therapeutics Inc
No change
1,077,080
$6,300,918,000 0.32%
Illumina Inc
No change
53,470
$5,581,199,000 0.28%
Monte Rosa Therapeutics Inc
No change
1,464,015
$5,475,416,000 0.28%
Dianthus Therapeutics Inc
No change
208,697
$5,401,078,000 0.27%
Desktop Metal, Inc.
Opened
1,104,871
$4,563,117,000 0.23%
Foghorn Therapeutics Inc.
No change
500,901
$2,880,181,000 0.15%
Tenaya Therapeutics Inc
No change
915,705
$2,838,686,000 0.14%
Fractyl Health Inc
No change
662,584
$2,829,234,000 0.14%
Autolus Therapeutics plc
No change
698,262
$2,429,952,000 0.12%
Benson Hill Inc
No change
15,352,271
$2,302,841,000 0.12%
Barinthus Biotherapeutics Pl
No change
1,513,644
$2,119,102,000 0.11%
Kronos Bio, Inc.
No change
1,438,232
$1,783,408,000 0.09%
Rani Therapeutics Hldgs Inc
No change
448,492
$1,704,270,000 0.09%
RAPT Therapeutics, Inc.
No change
540,270
$1,647,824,000 0.08%
Taysha Gene Therapies, Inc.
No change
640,882
$1,435,576,000 0.07%
Spero Therapeutics Inc
No change
889,979
$1,156,973,000 0.06%
Exact Sciences Corp.
No change
23,205
$980,411,000 0.05%
Alector, Inc.
No change
175,866
$798,432,000 0.04%
Hyperfine Inc
No change
898,720
$763,912,000 0.04%
Quince Therapeutics Inc
No change
189,122
$141,842,000 0.01%
Fulcrum Therapeutics Inc
No change
14,262
$88,424,000 0.00%
Repligen Corp.
No change
383
$48,281,000 0.00%
Mondee Holdings Inc
Closed
18,420
$42,550,000
Invitae Corp
No change
235,606
$0 0.00%
Cue Health Inc
No change
27,000
$0 0.00%
No transactions found
Showing first 500 out of 45 holdings